[Value of ipratropium bromide in asthma crisis in children].
Ipratropium bromide is a synthetic derivative of atropine with little absorption when used in inhalation, and therefore little secondary effects. The authors review its pharmacological properties and therapeutic efficacy in the treatment of asthma in children. Combined nebulized inhalation of ipratropium bromide and beta 2 sympathomimetic results in a more efficient and more sustained bronchodilatation than beta 2 sympathicomimetic alone in the treatment of acute asthma in children. Ipratropium bromide should be usefully introduced in the therapeutic scheme of acute asthma in children. Further studies will be necessary in order to determine its efficacy and tolerance in infants.
Delacourt
C
C
Service de pneumologie et allergologie pédiatriques, hôpital des Enfants-Malades, Paris, France.
de Blic
J
J
Lebourgeois
M
M
Scheinmann
P
P
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009241:Ipratropium / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013224:Status Asthmaticus / Q000188:drug therapy* / Q000503:physiopathology
D009241:Ipratropium
Intérêt du bromure d'ipratropium dans la crise d'asthme de l'enfant.